01.06.2016
- The European Commission has approved a subcutaneous formulation of Roche’s MabThera for chronic lymphocytic leukemia (CLL) which saves time and eases the treatment burden compared...
22.04.2016
- After giving it a priority review in January, the US Food and Drug Administration (FDA) has approved Venclexta (venetoclax), a novel of drug that targets a subset of leukemia...
19.01.2016
- Venetoclax, a novel leukemia treatment developed by biopharmaceutical company AbbVie, is to be reviewed by regulators in the US and EU. The drug is described as a potential first...
14.10.2015
- US agriculture and GMO giant Monsanto is facing lawsuits from farm workers in connection with its Roundup herbicide. One case charging that glyphosate, the primary ingredient in...
